194 related articles for article (PubMed ID: 20070832)
1. The prognostic value of cord blood analysis in erythropoietic protoporphyria: the 'Duesseldorf Cord Blood Study'.
Hanneken S; Siegesmund M; Bolsen K; Gardlo K; Neumann NJ
Photodermatol Photoimmunol Photomed; 2010 Feb; 26(1):7-9. PubMed ID: 20070832
[TBL] [Abstract][Full Text] [Related]
2. Prevention of murine erythropoietic protoporphyria-associated skin photosensitivity and liver disease by dermal and hepatic ferrochelatase.
Pawliuk R; Tighe R; Wise RJ; Mathews-Roth MM; Leboulch P
J Invest Dermatol; 2005 Jan; 124(1):256-62. PubMed ID: 15654982
[TBL] [Abstract][Full Text] [Related]
3. Automated imaging of circulating fluorocytes for the diagnosis of erythropoietic protoporphyria: a pilot study for population screening.
Lau KC; Lam CW
J Med Screen; 2008; 15(4):199-203. PubMed ID: 19106260
[TBL] [Abstract][Full Text] [Related]
4. Cholestyramine resin for erythropoietic protoporphyria with severe hepatic disease: a case report.
Yoo DJ; Lee HC; Yu E; Jin YJ; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS; Suh DJ
Korean J Hepatol; 2010 Mar; 16(1):83-8. PubMed ID: 20375647
[TBL] [Abstract][Full Text] [Related]
5. Trends in erythrocyte protoporphyrin IX concentration by age, sex and season among patients with erythropoietic protoporphyria-20 years of follow-up.
Heerfordt IM; Lerche CM; Wulf HC
Photodiagnosis Photodyn Ther; 2020 Dec; 32():101928. PubMed ID: 32717453
[TBL] [Abstract][Full Text] [Related]
6. Genetic study in a Singaporean patient with erythropoietic protoporphyria.
Chuah SY; Tee SI; Pramono ZA; Theng CT
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):269-71. PubMed ID: 22971195
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietic protoporphyria and early onset of cholestasis.
Khalili MJ; Farahmand F; Hirbod-Mobarakeh A; Yousefi A; Sotoudeh S; Monajemzadeh M; Razaghian A; Rezaei N
Turk J Pediatr; 2012; 54(6):645-50. PubMed ID: 23692792
[TBL] [Abstract][Full Text] [Related]
8. Excessive erythrocyte PPIX influences the hematologic status and iron metabolism in patients with dominant erythropoietic protoporphyria.
Delaby C; Lyoumi S; Ducamp S; Martin-Schmitt C; Gouya L; Deybach JC; Beaumont C; Puy H
Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):45-52. PubMed ID: 19268001
[TBL] [Abstract][Full Text] [Related]
9. A Novel Mutation in the FECH Gene in a Czech Family with Erythropoietic Protoporphyria and a Population Study of IVS3-48C Variant Contributing to the Disease.
Farrag MS; Kučerová J; Šlachtová L; Šeda O; Šperl J; Martásek P
Folia Biol (Praha); 2015; 61(6):227-32. PubMed ID: 26789144
[TBL] [Abstract][Full Text] [Related]
10. Acquired erythropoietic protoporphyria: A systematic review of the literature.
Snast I; Kaftory R; Sherman S; Edel Y; Hodak E; Levi A; Lapidoth M
Photodermatol Photoimmunol Photomed; 2020 Jan; 36(1):29-33. PubMed ID: 31374130
[TBL] [Abstract][Full Text] [Related]
11. Red blood cell exchange transfusion in two patients with advanced erythropoietic protoporphyria.
Eichbaum QG; Dzik WH; Chung RT; Szczepiorkowski ZM
Transfusion; 2005 Feb; 45(2):208-13. PubMed ID: 15660829
[TBL] [Abstract][Full Text] [Related]
12. X-linked dominant protoporphyria: The first reported Japanese case.
Ninomiya Y; Kokunai Y; Tanizaki H; Akasaka E; Nakano H; Moriwaki S
J Dermatol; 2016 Apr; 43(4):414-8. PubMed ID: 26387792
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietic protoporphyria patients in Slovenia.
Marko PB; Miljković J; Gorenjak M; Povalej P; Kansky A
Acta Dermatovenerol Alp Pannonica Adriat; 2007 Sep; 16(3):99-102, 104. PubMed ID: 17994169
[TBL] [Abstract][Full Text] [Related]
14. Ferrochelatase activities in patients with erythropoietic protoporphyria and their families.
Goerz G; Bunselmeyer S; Bolsen K; Schürer NY
Br J Dermatol; 1996 May; 134(5):880-5. PubMed ID: 8736329
[TBL] [Abstract][Full Text] [Related]
15. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
Bloomer JR; Wang Y; Singhal A; Risheg H
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S36-40. PubMed ID: 16819399
[TBL] [Abstract][Full Text] [Related]
16. How I treat erythropoietic protoporphyria and X-linked protoporphyria.
Leaf RK; Dickey AK
Blood; 2023 Jun; 141(24):2921-2931. PubMed ID: 36898083
[TBL] [Abstract][Full Text] [Related]
17. Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity.
Barman-Aksoezen J; Girelli D; Aurizi C; Schneider-Yin X; Campostrini N; Barbieri L; Minder EI; Biolcati G
J Inherit Metab Dis; 2017 May; 40(3):433-441. PubMed ID: 28185024
[TBL] [Abstract][Full Text] [Related]
18. Pitfalls in Erythrocyte Protoporphyrin Measurement for Diagnosis and Monitoring of Protoporphyrias.
Gou EW; Balwani M; Bissell DM; Bloomer JR; Bonkovsky HL; Desnick RJ; Naik H; Phillips JD; Singal AK; Wang B; Keel S; Anderson KE
Clin Chem; 2015 Dec; 61(12):1453-6. PubMed ID: 26482161
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of protoporphyrin IX in erythrocytes in patients with erythropoietic protoporphyria: A new treatment modality.
Wulf HC; Nissen CV; Philipsen PA
Photodiagnosis Photodyn Ther; 2020 Mar; 29():101582. PubMed ID: 31809913
[TBL] [Abstract][Full Text] [Related]
20. Late presentation of erythropoietic protoporphyria: case report and genetic analysis of family members.
Berroeta L; Man I; Goudie DR; Whatley SD; Elder GH; Ibbotson SH
Br J Dermatol; 2007 Nov; 157(5):1030-1. PubMed ID: 17711525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
